Stock market today: S&P 500 drops for fifth day as focus shifts to Powell’s speech
Amit Gupta, the Chief Executive Officer of Cardlytics, Inc. (NASDAQ:CDLX), recently sold shares of the company as part of a routine transaction. The stock, which InvestingPro data shows has declined nearly 59% over the past six months and currently trades below its Fair Value, operates with significant debt burden and volatile price movements. On January 3, Gupta sold 5,964 shares of common stock, generating a total of $21,869. The shares were sold at an average price of $3.667 per share, with prices ranging from $3.555 to $3.78.
This sale was conducted to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs) on January 1, 2025. Gupta did not sell shares for any other purpose. Following these transactions, Gupta holds 186,904 shares of Cardlytics' common stock.
In other recent news, Cardlytics has shared its third-quarter financial results for 2024, highlighting plans for growth and improved financial performance in the upcoming fourth quarter. The company's focus is on expansion and improvement through the introduction of new financial institution partnerships and operational and product enhancements. Cardlytics has also noted that these forward-looking statements are based on current assumptions and might be affected by various risk factors, which could lead to different actual results.
In addition, Cardlytics has not reported any specific financial misses during the call. The company's detailed financial information, including non-GAAP financial measures, is available in its recent press release and SEC filings. As these are recent developments, investors are advised to keep an eye on the unfolding situation. Please note that this report does not include any personal predictions or opinions and relies solely on verifiable facts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.